SCHEMBL3751895

SCHEMBL3751895

CN(C)c1ccc(C#Cc2c(N3CCOCC3)sc3c2CC(C)(C)CC3=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.40
PIK3CD O00329 3/20 0.40
PIK3CB P42338 3/20 0.40
PIK3CG P48736 3/20 0.40
ADK P55263 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
BRD4 O60885 1/20 0.35
ALDH1A1 P00352 3/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
KMT2A Q03164 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP11B2 P19099 1/20 0.33
POLB P06746 1/20 0.32
SLC2A1 P11166 1/20 0.32
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764957 0.88 PIK3CA (0.42) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3754871 0.88 PIK3CA (0.43) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3759332 0.86 PIK3CA (0.44) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3765808 0.85 PIK3CD (0.40) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3759747 0.82 PIK3CA (0.41) PIK3CAPIK3CDPIK3CBPIK3CGMAPT
SCHEMBL3758960 0.82 PIK3CA (0.40) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL3763646 0.81 PIK3CA (0.41) PIK3CAPIK3CDPIK3CBPIK3CGBRD4
SCHEMBL16161687 0.81 PIK3CA (0.39) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3766673 0.80 PIK3CA (0.43) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3760022 0.80 PIK3CA (0.43) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.